183 related articles for article (PubMed ID: 31853172)
1. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.
Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S
Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives.
Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P
J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid.
Li H; Lin H; Li J; Chen K; Chen Z; Zhang J; Huang Y; Zhao X; Ti H; Tao Y
Anticancer Agents Med Chem; 2024; 24(6):454-463. PubMed ID: 38204259
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity and DNA-binding properties of xanthone derivatives.
Shen R; Wang P; Tang N
J Fluoresc; 2010 Nov; 20(6):1287-97. PubMed ID: 20532595
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
[TBL] [Abstract][Full Text] [Related]
7. Influence of New Synthetic Xanthones on the Proliferation and Migration Potential of Cancer Cell Lines In Vitro.
Szkaradek N; Sypniewski D; Żelaszczyk D; Gałka S; Borzdziłowska P; Marona H; Bednarek I
Anticancer Agents Med Chem; 2019; 19(16):1949-1965. PubMed ID: 30950354
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer potential of novel xanthone derivatives with 3,6-substituted chains.
Liu C; Zhang M; Zhang Z; Zhang SB; Yang S; Zhang A; Yin L; Swarts S; Vidyasagar S; Zhang L; Okunieff P
Bioorg Med Chem; 2016 Sep; 24(18):4263-4271. PubMed ID: 27448774
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro Evaluation of the Anticancer Potential of New Aminoalkanol Derivatives of Xanthone.
Szkaradek N; Sypniewski D; Waszkielewicz AM; Gunia-Krzyżak A; Galilejczyk A; Gałka S; Marona H; Bednarek I
Anticancer Agents Med Chem; 2016; 16(12):1587-1604. PubMed ID: 27039927
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study.
Woo S; Jung J; Lee C; Kwon Y; Na Y
Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents.
Lemos A; Gomes AS; Loureiro JB; Brandão P; Palmeira A; Pinto MMM; Saraiva L; Sousa ME
Molecules; 2019 May; 24(10):. PubMed ID: 31121972
[TBL] [Abstract][Full Text] [Related]
12. 'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.
Li X; Wu Y; Wang Y; You Q; Zhang X
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077076
[No Abstract] [Full Text] [Related]
13. Multidimensional optimization of promising antitumor xanthone derivatives.
Azevedo CM; Afonso CM; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Corrêa AG; Reis S; Pinto MM
Bioorg Med Chem; 2013 Jun; 21(11):2941-59. PubMed ID: 23623253
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity and DNA-binding properties of isoeuxanthone derivatives.
Wang HF; Yan H; Gao X; Niu B; Guo R; Wei L; Xu B; Tang N
Chem Pharm Bull (Tokyo); 2014; 62(3):260-6. PubMed ID: 24583780
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a Highly Potent and Novel Gambogic Acid Derivative as an Anticancer Drug Candidate.
Ling H; Li H; Chen M; Lai B; Zhou H; Gao H; Zhang J; Huang Y; Tao Y
Anticancer Agents Med Chem; 2021; 21(9):1110-1119. PubMed ID: 32268871
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, SAR and biological evaluation of natural and non-natural hydroxylated and prenylated xanthones as antitumor agents.
Zhang X; Li X; Ye S; Zhang Y; Tao L; Gao Y; Gong D; Xi M; Meng H; Zhang M; Gao W; Xu X; Guo Q; You Q
Med Chem; 2012 Nov; 8(6):1012-25. PubMed ID: 22779801
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the pharmacophoric motif of the caged Garcinia xanthones.
Chantarasriwong O; Cho WC; Batova A; Chavasiri W; Moore C; Rheingold AL; Theodorakis EA
Org Biomol Chem; 2009 Dec; 7(23):4886-94. PubMed ID: 19907779
[TBL] [Abstract][Full Text] [Related]
19. Recent cancer drug development with xanthone structures.
Na Y
J Pharm Pharmacol; 2009 Jun; 61(6):707-12. PubMed ID: 19505360
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure-activity relationship and in vitro pharmacodynamics of A-ring modified caged xanthones in a preclinical model of inflammatory breast cancer.
Chantarasriwong O; Milcarek AT; Morales TH; Settle AL; Rezende CO; Althufairi BD; Theodoraki MA; Alpaugh ML; Theodorakis EA
Eur J Med Chem; 2019 Apr; 168():405-413. PubMed ID: 30831408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
